Summary

The Non-steroidal Anti-inflammatory Drugs (NSAID) market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

market size and forecast

Regional market size, production data and export & import

Key manufacturers profile, products & services, sales data of business

market size by Major Application

market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:

Glaxo Smith Kline

Johnson & Johnson

Bayer

Novacap

Abbott

Pfizer

Geri-Care Pharmaceuticals

Perrigo Company

Kopran

Merck Sharp & Dohme

Sun Pharmaceutical Industries

Reddy Pharmaceuticals

Major applications as follows:

Back Pain Treatment

Osteoarthritis Treatment

Others

Major Type as follows:

Aspirin

Ibuprofen

Naproxen

Nabumetone

Others

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Glaxo Smith Kline
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Johnson & Johnson
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Bayer
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Novacap
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Abbott
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Pfizer
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Geri-Care Pharmaceuticals
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Perrigo Company
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Kopran
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Merck Sharp & Dohme
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Sun Pharmaceutical Industries
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12 Reddy Pharmaceuticals
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Back Pain Treatment
4.1.1 Overview
4.1.2 Back Pain Treatment Market Size and Forecast
4.2 Osteoarthritis Treatment
4.2.1 Overview
4.2.2 Osteoarthritis Treatment Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.By Aspirin
5.1 Aspirin
5.1.1 Overview
5.1.2 Aspirin Market Size and Forecast
5.2 Ibuprofen
5.2.1 Overview
5.2.2 Ibuprofen Market Size and Forecast
5.3 Naproxen
5.3.1 Overview
5.3.2 Naproxen Market Size and Forecast
5.4 Nabumetone
5.4.1 Overview
5.4.2 Nabumetone Market Size and Forecast
5.5 Others
5.5.1 Overview
5.5.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion